Search research articles
Contact Us
Filters
Showing results (1-10 of 8) with videos related to
Page
of 1
Sort By:
Bulletin Du Cancer
|
February 29, 2008
[New diagnostic markers for malignant pleural mesothelioma]
Bogdan-Dragos Grigoriu, Marc Grégoire, Bachar Chahine, et al.
BMC Cancer
|
January 22, 2008
Loss of Endocan tumorigenic properties after alternative splicing of exon 2
Florence Depontieu, Bogdan-Dragos Grigoriu, Arnaud Scherpereel, et al.
Journal of Infection in Developing Countries
|
February 12, 2020
Endocan - a potential diagnostic marker for early onset sepsis in neonates
Gabriela Ildiko Zonda, Radu Zonda, Andrei Tudor Cernomaz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 17, 2007
Utility of osteopontin and serum mesothelin in malignant pleural mesothelioma diagnosis and prognosis assessment
Bogdan-Dragos Grigoriu, Arnaud Scherpereel, Patrick Devos, et al.
BMC Pulmonary Medicine
|
May 25, 2016
Comparison of next generation sequencing, SNaPshot assay and real-time polymerase chain reaction for lung adenocarcinoma EGFR mutation assessment
Andrei-Tudor Cernomaz, Ina Iuliana Macovei, Ionut Pavel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 11, 2006
Endocan expression and relationship with survival in human non-small cell lung cancer
Bogdan Dragos Grigoriu, Florence Depontieu, Arnaud Scherpereel, et al.
BMC Cancer
|
July 3, 2013
Defect in recruiting effector memory CD8+ T-cells in malignant pleural effusions compared to normal pleural fluid
Arnaud Scherpereel, Bogdan Dragos Grigoriu, Marc Noppen, et al.
Breathe (Sheffield, England)
|
February 18, 2017
Thoracic oncology HERMES: European curriculum recommendations for training in thoracic oncology
Fernando Gamarra, Julie-Lyn Noël, Alessandro Brunelli, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 8) with videos related to
Sort By:
Page
of 1
Bulletin Du Cancer
|
February 29, 2008
[New diagnostic markers for malignant pleural mesothelioma]
Bogdan-Dragos Grigoriu, Marc Grégoire, Bachar Chahine, et al.
BMC Cancer
|
January 22, 2008
Loss of Endocan tumorigenic properties after alternative splicing of exon 2
Florence Depontieu, Bogdan-Dragos Grigoriu, Arnaud Scherpereel, et al.
Journal of Infection in Developing Countries
|
February 12, 2020
Endocan - a potential diagnostic marker for early onset sepsis in neonates
Gabriela Ildiko Zonda, Radu Zonda, Andrei Tudor Cernomaz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 17, 2007
Utility of osteopontin and serum mesothelin in malignant pleural mesothelioma diagnosis and prognosis assessment
Bogdan-Dragos Grigoriu, Arnaud Scherpereel, Patrick Devos, et al.
BMC Pulmonary Medicine
|
May 25, 2016
Comparison of next generation sequencing, SNaPshot assay and real-time polymerase chain reaction for lung adenocarcinoma EGFR mutation assessment
Andrei-Tudor Cernomaz, Ina Iuliana Macovei, Ionut Pavel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 11, 2006
Endocan expression and relationship with survival in human non-small cell lung cancer
Bogdan Dragos Grigoriu, Florence Depontieu, Arnaud Scherpereel, et al.
BMC Cancer
|
July 3, 2013
Defect in recruiting effector memory CD8+ T-cells in malignant pleural effusions compared to normal pleural fluid
Arnaud Scherpereel, Bogdan Dragos Grigoriu, Marc Noppen, et al.
Breathe (Sheffield, England)
|
February 18, 2017
Thoracic oncology HERMES: European curriculum recommendations for training in thoracic oncology
Fernando Gamarra, Julie-Lyn Noël, Alessandro Brunelli, et al.
Page
of 1